How should patients treated with α-blockers be followed? Insights from an ambulatory blood pressure monitoring database

Journal of Hypertension

Volumn 24, Issue 5, 2006, Pages 861-865

  Ben Dov, Iddo Z ^a   Ben Arie, Liora ^a   Mekler, Judith ^a   Bursztyn, Michael ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Adrenergic alpha antagonists; Ambulatory blood pressure monitoring; Circadian rhythm; Dipping; Orthostatic hypotension

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; NITRATE; PHENOXYBENZAMINE; TAMSULOSIN; TERAZOSIN; VASODILATOR AGENT;

ADULT; AGE; AGED; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; FOLLOW UP; GENDER; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONITOR; POLYPHARMACY; PRIORITY JOURNAL; STANDING; SUPINE POSITION;

EID: 33646336905     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000222755.69358.72     Document Type: Article

References (36)

1. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
2. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Diuretic versus α-blocker as first-step antihypertensive therapy final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2003; 42:239-246.
3. ALLHAT Investigators. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2000; 283:1967-1975.
4. Lehtonen A and Finnish Multicenter Study Group. Doxazosin effects on insulin and glucose in hypertensive patients. Am Heart J 1991; 121:1307-1311.
5. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347:797-805.
6. Pickering TG. The clinical significance of diurnal blood pressure variations, dippers and nondippers. Circulation 1990; 81:700-702.
7. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in subjects with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20:2183-2189.
8. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46:156-161.
9. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111:1777-1783.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al., and the National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003; 289:2560-2572.
11. Berrut G, Hallab M, Bouhanick B, Chameau AM, Marre M, Fressinaud P. Value of ambulatory blood pressure monitoring in type I (insulin-dependent) diabetic patients with incipient diabetic nephropathy. Am J Hypertens 1994; 7:222-227.
12. Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1999; 100:1635-1638.
13. Kario K, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of α-adrenergic blocker, doxazosin: Results from the HALT study. Hypertension 2000; 35:4787-4794.
14. Ebata H, Hojo Y, Ikeda U, Ishide H, Natsume T, Shimada K. Differential effects of an α-1 blocker (doxazosin) on diurnal blood pressure variation in dipper and non-dipper type hypertension. Hypertens Res 1995; 18: 125-130.
15. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45:240-245.
16. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546.
17. Suzuki Y, Kuwajima I, Aono T, Kanemaru A, Nishinaga M, Shibata H, Ozawa T. Prognostic value of nighttime blood pressure in the elderly: a prospective study of 24-hour blood pressure. Hypertens Res 2000; 23:323-330.
18. Schafers RF, Fokuhl B, Wasmuth A, Schumacher H, Taguchi K, de Mey C, et al. Differential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosin. Br J Clin Pharmacol 1999; 47:67-74.
19. Michel MC, Flannery MT, Narayan P. Worldwide experience with alfuzosin and tamsulosin. Urology 2001; 58:508-516.
20. Sega R, Marazzi ME, Bombelli M, Vulpis V, Antonacci A, Leto di Priolo S, et al. Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension. Pharmacol Res 1991; 24:41-52.
21. Groppelli A, Omboni S, Parati G, Mancia G. Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. Hypertension 1992; 20:227-232.
22. Perk G, Mekler J, Bursztyn M. Ambulatory pulse pressure is a relatively sleep independent variable. J Hypertens 2003; 21:723-728.
23. Ben-Dov IZ, Ben-Arieh L, Mekler J, Bursztyn M. Blood pressure dipping is reproducible in clinical practice. Blood Press Monit 2005; 10:79-84.
24. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans. Circulation 2005; 111:697-716.
25. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23:697-701.
26. Perk G, Mekler J, Ben Ishay D, Bursztyn M. Non-dipping in diabetic patients: insights from the siesta. J Hum Hypertens 2002; 16:435-438.
27. Perk G, Ben-Arie L, Mekler J, Bursztyn M. Dipping status may be determined by nocturnal urination. Hypertension 2001; 37:749-752.
28. Sherwood A, Steffen PR, Blumenthal JA, Kuhn C, Hinderliter AL. Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens 2002; 15:111-118.
29. Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab 1985; 60:1210-1215.
30. Panza JA, Epstein SE, Quyyumi AA. Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 1991; 325:986-990.
31. Hermida RC, Calvo C, Ayala DE, Dominguez MJ, Covelo M, Fernandez JR, et al. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol Int 2004; 21:277-296.
32. Carruthers SG. Adverse effects of alpha 1-adrenergic blocking drugs. Drug Saf 994; 11:12-20.
33. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38:852-857.
34. Izzo JL Jr, Licht MR, Smith RJ, Larrabee PS, Radke KJ, Kallay MC. Chronic effects of direct vasodilation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension. Am J Cardiol 1987; 60:303-308.
35. Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1997; 96:1859-1862.
36. Ben-Dov IZ, Bursztyn M. Ambulatory blood pressure monitoring may be a prognostic marker in people with heart failure [Commentary]. Evid Based Cardiovasc Med 2005; 9:197-199.